1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstuctive pulmonary disease (updated 2014) [EB/OL] http://www.goldcopd.org/uploads/users/files/GOLD_Report2014_Feb07.pdf .
2. Price D, Yawn B, Brusselle G, Rossi A. Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. Prim Care Respir J. 2013;22:92–100.
3. Xie Y, Li JS, Yu XQ. Thinking on the junction point of Chinese Medicine in Comparative Effectiveness Research on Chronic Obstructive Pulmonary Disease. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014;34(5):611–6.
4. Li JS, Wang ZW, Yu XQ, Wang MH, Li SY. Clinical efficacy and safety of TCM for COPD at stable phase: a systematic review. Liaoning Zhong Yi Za Zhi. 2010;37(2):229–32.
5. Li SY, Zhou QW, Wang MH, Wang HF, Wu JZ. Effect of bufeiyishen granule on pulmonary ventilation function and immunological function of patients with chronic obstructive pulmonary disease in remission phase: a randomized grouping and placebo controlled study. Zhongguo Lin Chuang Kang Fu. 2006;10(7):145–7.